Insider Shareholders with Direct Ownership of Chinook Therapeutics, Inc. (KDNY)
This section provides a comprehensive overview of the insiders with direct ownership of Chinook Therapeutics, Inc. (KDNY). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
CHINOOK THERAPEUTICS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Versant Venture Capital Vii, L.P.
> 10% Shareholder |
0 | 1,819,953 | 2,913,070 $0 | 3 |
Apr 04, 2022
Reduced 19.6%
|
|
Davis Jerel
Director |
742,821 | 742,821 | 733,770 $0 | 8 |
May 26, 2023
Added 0.45%
|
|
Ross Haghighat
Director |
3,300 | 0 | 124,546 $0 | 1 |
May 26, 2023
Added 2.58%
|
|
Alan Glicklich
Chief Medical Officer |
32,771 | 24,880 | 7,891 $0 | 6 |
Feb 11, 2022
Reduced 23.25%
|
|
Srinivas Akkaraju
Director |
3,300 | 3,300 | 3,300 $0 | 2 |
May 26, 2023
Added 50.0%
|
|
Andrew James King
Chief Scientific Officer |
75,573 | 75,573 | 0 $0 | 27 |
Aug 11, 2023
Reduced 100.0%
|
|
Michelle Renee Griffin
Director |
3,300 | 3,300 | 0 $0 | 2 |
Aug 11, 2023
Reduced 100.0%
|
|
Dolca Thomas
Director |
13,300 | 13,300 | 0 $0 | 3 |
Aug 11, 2023
Reduced 100.0%
|
|
Eric Dobmeier
President, CEO |
423,123 | 420,723 | 0 $0 | 31 |
Aug 11, 2023
Reduced 100.0%
|
|
William Mariner Greenman
Director |
4,963 | 24,798 | 0 $0 | 4 |
Aug 11, 2023
Reduced 100.0%
|
|
Mahesh Krishnan
Director |
2,199 | 2,199 | 0 $0 | 3 |
Aug 11, 2023
Reduced 100.0%
|
|
Eric Bjerkholt
Chief Financial Officer |
45,030 | 55,534 | 0 $0 | 11 |
Aug 11, 2023
Reduced 100.0%
|
|
Tom Frohlich
Chief Operating Officer |
257,497 | 257,497 | 0 $0 | 22 |
Aug 11, 2023
Reduced 100.0%
|